cleanup: rejected/shard_00368.jsonl fully superseded
Browse files
rejected/shard_00368.jsonl
DELETED
|
@@ -1 +0,0 @@
|
|
| 1 |
-
{"session_id": "atlas-631b2c17e8", "tier": "text", "task_instruction": "Determine the prognosis for a patient with AML based on their cytogenetic abnormalities.", "source": "llm_generated", "grounded_in": "wikitext-103", "steps": [{"step_index": 0, "observation": {"text": "The patient has AML.", "image_path": null, "audio_path": null}, "reasoning": "Given that AML is the disease in question, we need to consider the cytogenetic abnormalities to determine prognosis.", "action": {"type": "text_response", "value": ""}, "refers_back_to": null}, {"step_index": 1, "observation": {"text": "Cytogenetics is the primary factor in prognosis for AML.", "image_path": null, "audio_path": null}, "reasoning": "Cytogenetics, which refers to the chromosomal structure of the leukemic cells, is the most important factor in predicting the outcome of AML treatment.", "action": {"type": "text_response", "value": ""}, "refers_back_to": null}, {"step_index": 2, "observation": {"text": "The patient's cytogenetic profile is normal.", "image_path": null, "audio_path": null}, "reasoning": "If the patient has 'normal' cytogenetics, they fall into the intermediate risk group.", "action": {"type": "text_response", "value": ""}, "refers_back_to": null}, {"step_index": 3, "observation": {"text": "Normal cytogenetics correspond to an intermediate risk group.", "image_path": null, "audio_path": null}, "reasoning": "This means the patient's prognosis is neither as favorable as those with specific abnormalities like (15;17) translocation nor as poor as those with other abnormalities.", "action": {"type": "text_response", "value": ""}, "refers_back_to": null}], "task_complexity": "high", "language": "en", "license": "CC-BY-SA-3.0", "date_created": "2026-08-18", "_structural_pass": false, "_structural_reason": "step 0 missing 'action'", "_repaired": false, "_seed_type": "wikitext", "_seed_content": "The single most important prognostic factor in AML is cytogenetics , or the chromosomal structure of the leukemic cell . Certain cytogenetic abnormalities are associated with very good outcomes ( for example , the ( 15 ; 17 ) translocation in acute promyelocytic leukemia ) . About half of people with AML have \" normal \" cytogenetics ; they fall into an intermediate risk group . A number of other cytogenetic abnormalities are known to associate with a poor prognosis and a high risk of relapse after treatment .", "_reject_reason": "structural: step 0 missing 'action'"}
|
|
|
|
|
|